61958-1401 NDC - TYBOST (COBICISTAT)

Drug Information

Product NDC: 61958-1401

Proprietary Name: Tybost

Non Proprietary Name: COBICISTAT

Active Ingredient(s):
  • 150 mg/1 COBICISTAT


Administration Route(s): ORAL

Dosage Form(s): TABLET, FILM COATED

Pharmacy Class(es):
  • Breast Cancer Resistance Protein Inhibitors [MoA];
  • Cytochrome P450 2D6 Inhibitors [MoA];
  • Cytochrome P450 3A Inhibitor [EPC];
  • Cytochrome P450 3A Inhibitors [MoA];
  • Organic Anion Transporting Polypeptide 1B1 Inhibitors [MoA];
  • Organic Anion Transporting Polypeptide 1B3 Inhibitors [MoA];
  • P-Glycoprotein Inhibitors [MoA]

Labeler Information

Labeler Name: Gilead Sciences, Inc.
Product Type: HUMAN PRESCRIPTION DRUG
FDA Application Number: NDA203094
Marketing Category: NDA
Start Marketing Date:9/24/2014

Package Information

No. Package Code Package Description Billing Unit
161958-1401-130 TABLET, FILM COATED in 1 BOTTLE (61958-1401-1)EA

NDC Record

Field Name Field Value Definition
PRODUCT NDC61958-1401The labeler code and product code segments of the National Drug Code number, separated by a hyphen. Asterisks are no longer used or included within the product code segment to indicate certain configurations of the NDC.
PRODUCT TYPE NAMEHUMAN PRESCRIPTION DRUGIndicates the type of product, such as Human Prescription Drug or Human Over the Counter Drug. This data element matches the “Document Type” field of the Structured Product Listing.
PROPRIETARY NAMETybostThe proprietary name also known as the trade name is the name of the product chosen by the medication labeler for marketing purposes.
NON PROPRIETARY NAMECOBICISTATThe non-proprietary name is sometimes called the generic name. The generic name usually includes the active ingredient(s) of the product.
DOSAGE FORM NAMETABLET, FILM COATEDThe translation of the dosage form Code submitted by the firm.
ROUTE NAMEORALThe translation of the route code submitted by the firm, indicating route of administration.
START MARKETING DATE9/24/2014This is the date that the labeler indicates was the start of its marketing of the drug product.
MARKETING CATEGORY NAMENDAProduct types are broken down into several potential Marketing Categories, such as NDA/ANDA/BLA, OTC Monograph, or Unapproved Drug. One and only one Marketing Category may be chosen for a product, not all marketing categories are available to all product types. Currently, only final marketed product categories are included. The complete list of codes and translations can be found at www.fda.gov/edrls under Structured Product Labeling Resources.
APPLICATION NUMBERNDA203094This corresponds to the NDA, ANDA, or BLA number reported by the labeler for products which have the corresponding Marketing Category designated. If the designated Marketing Category is OTC Monograph Final or OTC Monograph Not Final, then the Application number will be the CFR citation corresponding to the appropriate Monograph (e.g. “part 341”). For unapproved drugs, this field will be null.
LABELER NAMEGilead Sciences, Inc.Name of Company corresponding to the labeler code segment of the Product NDC.
SUBSTANCE NAMECOBICISTATAn active ingredient is the substance responsible for the medicinal effects of a product specified by the substance's molecular structure or if the molecular structure is not known, defined by an unambiguous definition that identifies the substance. Each active ingredient name is the preferred term of the UNII code submitted.
ACTIVE NUMERATOR STRENGTH150 
ACTIVE INGRED UNITmg/1 
PHARM CLASSESBreast Cancer Resistance Protein Inhibitors [MoA], Cytochrome P450 2D6 Inhibitors [MoA], Cytochrome P450 3A Inhibitor [EPC], Cytochrome P450 3A Inhibitors [MoA], Organic Anion Transporting Polypeptide 1B1 Inhibitors [MoA], Organic Anion Transporting Polypeptide 1B3 Inhibitors [MoA], P-Glycoprotein Inhibitors [MoA] 

Download Record

Download this NDC record in Text format: Export

Download this NDC record in Excel (CSV) format: Export

Download this NDC record in XML format: Export

This page was last updated on: 2/1/2023